HomeNewsBusinessInterview | TCS to recruit 40,000 from campuses in FY22, says CFO V Ramakrishnan

Interview | TCS to recruit 40,000 from campuses in FY22, says CFO V Ramakrishnan

In an interaction with Moneycontrol, TCS CFO V Ramakrishnan talks about what drove growth for the seasonally weak December quarter, demand environment, hiring and work from home.

January 11, 2021 / 07:22 IST
Story continues below Advertisement

India’s largest IT services provider Tata Consultancy Services (TCS) on January 8 reported its strongest results in the last nine years for the quarter ending December 2020, a seasonally weak quarter.

TCS CEO Rajesh Gopinathan told media persons during the results announcement that the company is confident about achieving a double-digit growth trajectory in FY22 on the back of digital transformation.

Story continues below Advertisement

In an interaction with Moneycontrol, V Ramakrishnan, CFO, talks about what drove growth for the seasonally weak December quarter, demand environment, hiring, and work from home.

Edited Excerpts:

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show